What is UroGen Pharma's capex?

UroGen Pharma (URGN) reported capex of $54K in Q1 2026.

How has UroGen Pharma's capex changed year-over-year?

UroGen Pharma's capex increased by 22.7% year-over-year, from $44K to $54K.

What is the long-term trend for UroGen Pharma's capex?

Over 4 years (2021 to 2025), UroGen Pharma's capex has grown at a -21.3% compound annual growth rate (CAGR), from $752K to $289K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

UroGen Pharma URGN CapEx

CapEx at other companies

Bristol-Myers SquibbBMY

$347M+33.5%

PfizerPFE

$436M-22.7%

Johnson & JohnsonJNJ

$1.05B+31.9%

Merck & Co.MRK

$991M-25.4%

ImmunityBio, Inc.IBRX

$1.78M+58.4%

Tyra Biosciences, Inc.TYRA

$88K+529%

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.71B+71.7%

Enterprise value$1.8B+80.9%

P/S12.2×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's capex?: UroGen Pharma (URGN) reported capex of $54K in Q1 2026.
How has UroGen Pharma's capex changed year-over-year?: UroGen Pharma's capex increased by 22.7% year-over-year, from $44K to $54K.
What is the long-term trend for UroGen Pharma's capex?: Over 4 years (2021 to 2025), UroGen Pharma's capex has grown at a -21.3% compound annual growth rate (CAGR), from $752K to $289K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.